<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE html>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:epub="http://www.idpf.org/2007/ops" lang="en">
<head>
<meta http-equiv="default-style" content="application/xhtml+xml; charset=utf-8"/>
<title>Brunner &#38; Suddarth&#8217;s Textbook of Medical-Surgical Nursing, 15e</title>
<link rel="stylesheet" type="text/css" href="style.css"/>
</head>
<body epub:type="bodymatter">
<div id="main_container">
<section epub:type="division">
<h4 class="h4" id="s1193">Malignancy</h4>
<p class="nonindent">Cancers, particularly stomach, pancreatic, lung, and ovarian cancers, are often associated with thrombophilia with significant risk for VTE. VTE contributes to morbidity and mortality of patients with cancer, with a fatal PE being three times more common in patients with cancer than in those without cancer. Patients with cancer have a five- to sevenfold increased risk of developing VTE, and those who develop VTE at diagnosis of cancer or within a year of diagnosis tend to have a significantly worse prognosis than patients with cancer without VTE. A diagnosis of VTE is a serious complication of cancer that adversely affects a patient&#x2019;s quality of life and reduces overall survival. Anticoagulation may be difficult to manage and thromboses can progress despite adequate doses of anticoagulants. LMWH may be more effective than warfarin in treating this group of patients (<a href="#bib2171">Razak, Jones, Bhandari, et&#x00A0;al., 2018</a>).</p>
<h5 class="h5" id="s1194">Medical Management</h5>
<p class="nonindent">The primary treatment for thrombotic disorders is anticoagulation. However, when to treat and how long to treat with anticoagulant medications is controversial. Anticoagulation therapy is not without risk, with the most significant risk of bleeding. Anticoagulant medications used to treat a variety of thromboses are discussed in Chapter 26.</p>
<h5 class="h5" id="s1195">Nursing Management</h5>
<p class="nonindent">Patients with thrombotic disorders should be counseled to avoid activities that lead to circulatory stasis (e.g., immobility, crossed legs). Exercise, especially ambulation, should be performed frequently throughout the day, especially during long trips by car or plane. Anti-embolism stockings may be prescribed and patients often need instruction in how to use them properly. Surgery increases risk for thrombosis significantly.</p>
<p class="indent">Medications that alter platelet aggregation, such as low-dose aspirin or clopidogrel, may be prescribed. Some patients require lifelong anticoagulation therapy.</p>
<p class="indent">Patients with thrombotic disorders, particularly those with thrombophilia, should be evaluated for concurrent risk factors for thrombosis and should avoid them whenever possible. For example, products containing tobacco and nicotine should be avoided, blood pressure should be controlled, and alcohol consumption limited. In some instances, younger patients with thrombophilia may not need prophylactic anticoagulation, but when concomitant risk factors (e.g., pregnancy), increasing age, or subsequent thrombotic events are present, prophylactic or long-term anticoagulation therapy may be needed. Being able to provide the health care provider with an accurate health history can be extremely useful and help in guiding the selection of the appropriate interventions. Patients need to be aware of risk factors for thrombosis and how they can be reduced or eliminated, such as avoiding tobacco, using alternative forms of contraception, avoiding immobility, and maintaining a healthy weight. Patients with hereditary disorders should encourage their siblings and children to be tested for the disorder.</p>
<p class="indent">When a patient with a thrombotic disorder is hospitalized, frequent assessment should be performed to promote early recognition of signs and symptoms of thrombus formation, <span epub:type="pagebreak" id="page947" title="947"></span>particularly in the legs (DVT) and lungs (PE). Ambulation or range-of-motion exercises as well as anti-embolism stockings or sequential compression devices are used to decrease venous stasis.</p>
<p class="reviewpH1">CRITICAL THINKING EXERCISES</p>
<div class="review">
<p class="reviewpNL1First"><span class="sblue">1</span> <img class="m" src="images/xxvii-3.jpg" alt=""/> A 72-year-old man presents to the emergency department complaining of acute shortness of breath and chest pain. He reports increasing fatigue, exertional dyspnea, dull abdominal pain, and weight loss over the last few months. His CBC reveals a normal WBC count and platelet count; however, the hemoglobin is 7.2 mg/dL and the hematocrit is 22.3%. The MCV is reduced. Iron deficiency anemia is suspected. What are your priority interventions targeted at relieving the patient&#x2019;s symptoms? What other medical interventions do you anticipate might be prescribed? What additional laboratory tests do you anticipate for this patient?</p>
<p class="reviewline">&#x00A0;</p>
<p class="reviewpNL1Middle"><span class="sblue">2</span> <img class="m" src="images/xxvii-1.jpg" alt=""/> A 23-year-old female patient with sickle cell disease tells you during a routine office visit that she would like to become pregnant. Her condition has been well controlled with hydroxyurea. She takes ibuprofen on a regular basis for chronic pain. What additional information should you collect in the patient history? What challenges do you anticipate in caring for this patient? What other members of the interdisciplinary team do you think should be consulted to be part of the patient&#x2019;s prenatal care?</p>
<p class="reviewline">&#x00A0;</p>
<p class="reviewpNL1First"><span class="sblue">3</span> <img class="m" src="images/xxvii-2.jpg" alt=""/> Your 44-year-old female neighbor tells you that her brother has been &#x201C;nagging her&#x201D; to get tested for hemochromatosis since he was diagnosed with this disease a few months ago. Her brother has periodic therapeutic phlebotomies to treat his disease, and she feels her lifestyle is too busy to support these types of treatments. She tells you that she &#x201C;feels fine&#x201D; and wonders how likely it is that she has hemochromatosis, and if she does, whether treatment would be needed. What are the risks for hemochromatosis? If your neighbor does have hemochromatosis, what is the strength of the evidence for best treatment options for her?</p>
</div>
<p class="BIBLIOGRAPHYpTitle"><strong>REFERENCES</strong></p>
<p class="TOPICpBIBLIOGRAPHYpPARA">*Asterisk indicates nursing research.</p>
<p class="TOPICpBIBLIOGRAPHYpPARApIndent">**Double asterisk indicates classic reference.</p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE">Books</p>
<p class="bib" id="bib2080">Bunn, H. F. (2017a). Overview of anemias. In J. C. Aster &#x0026; H. F Bunn (Eds.). <em>Pathophysiology of blood disorders</em> (2nd ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2081">Bunn, H. F. (2017b). Sickle cell disease. In J. C. Aster &#x0026; H. F. Bunn (Eds.). <em>Pathophysiology of blood disorders</em> (2nd ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2082">Bunn, H. F., &#x0026; Bauer, K. A. (2017). Thrombotic disorders. In J. C. Aster &#x0026; H. F. Bunn (Eds.). <em>Pathophysiology of blood disorders</em> (2nd ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2083">Bunn, H. F., &#x0026; Heeney, M. M. (2017). Iron homeostasis: Deficiency and overload. In J. C. Aster &#x0026; H. F. Bunn (Eds.). <em>Pathophysiology of blood disorders</em> (2nd ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2084">Comerford, K. C., &#x0026; Durkin, M. T. (2020). <em>Nursing 2020 drug handbook</em>. Philadelphia, PA: Wolters Kluwer.</p>
<p class="bib" id="bib2085">Dale, D. C., &#x0026; Welte, K. (2016). Neutropenia and neutrophilia. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2086">Diz-Kucukkaya, R., &#x0026; Lopez, J. (2016). Thrombocytopenia. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2087">Elder, J. D., Winland-Brown, J. E., &#x0026; Porter, B. O. (2019). Hematologic disorders. In L. M. Dunphy, J. E. Winland-Brown, B. O. Porter, et&#x00A0;al. (Eds.). <em>Primary care: The art and science of advance practice nursing&#x2014;An interprofessional approach</em> (5th ed.). Philadelphia, PA: FA Davis.</p>
<p class="bib" id="bib2088">Escobar, M. A., &#x0026; Key, N. S. (2016). Hemophilia A and hemophilia B. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2089">Fischbach, F. T., &#x0026; Fischbach, M. A. (2018). <em>A manual of laboratory and diagnostic tests</em> (10th ed.). Philadelphia, PA: Wolters Kluwer.</p>
<p class="bib" id="bib2090">Ganz, T. (2016). Iron deficiency and overload. In L. M. Dunphy, J. E. Winland-Brown, B. O. Porter, et&#x00A0;al. (Eds.). <em>Primary care: The art and science of advance practice nursing&#x2014;An interprofessional approach</em> (5th ed.). Philadelphia, PA: FA Davis.</p>
<p class="bib" id="bib2091">Green, R. (2016). Folate, cobalamin, and megaloblastic anemias. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2092">Heuser, C., &#x0026; Branch, W. (2019). Diagnosis and management of antiphospholipid syndrome. In E. R. Norwitz, C. M. Zelop, D. A. Miller, et&#x00A0;al. (Eds.). <em>Evidence-based obstetrics and gynecology</em>. Hoboken, NJ: Wiley Blackwell.</p>
<p class="bib" id="bib2093">Kaushansky, K. (2016). Reactive thrombocytosis. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2094">Levi, M., &#x0026; Seligsohn, U. (2016). Disseminated intravascular coagulation. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2095">Levi, M., Seligsohn, U., &#x0026; Kaushansky, K. (2016). Classification, clinical manifestations, and evaluation of disorders of hemostasis. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2096">Middeldorp, S., &#x0026; Coppens, M. (2016). Hereditary thrombophilia. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2097">Nair, M. (2018). The blood and associated disorders. In I. Peate (Ed.). <em>Fundamentals of applied pathophysiology</em> (3rd ed.). Hoboken, NJ: John Wiley &#x0026; Sons.</p>
<p class="bib" id="bib2098">Natrajan K., &#x0026; Kutlar, A. (2016). Disorders of hemoglobin structure: Sickle cell anemia and related abnormalities. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2099">Packman, C. H. (2016). Hemolytic anemia resulting from immune injury. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2100">Prchal, J. T. (2016a). Clinical manifestations and classification of erythrocyte disorders. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2101">Prchal, J. T. (2016b). Primary and secondary erythrocytoses. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2102">Rand, J. H., &#x0026; Wolgast, L. (2016). The antiphospholipid syndrome. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2103">Segel, G. B., &#x0026; Lichtman, M. A. (2016). Aplastic anemia: Acquired and inherited. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2104">van Solinge, W. W., &#x0026; van Wijk, R. (2016). Erythrocyte enzyme disorders. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2105">Vasu, S., &#x0026; Caligiuri, M. A. (2016). Lymphocytosis and lymphopenia. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="bib" id="bib2106">Weatherall, D. J. (2016). The thalassemias: Disorders of globin synthesis. In K. Kaushansky, M. A. Lichtman, J. T. Prchal, et&#x00A0;al. (Eds.). <em>Williams hematology</em> (9th ed.). New York: McGraw-Hill Medical.</p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE"><span epub:type="pagebreak" id="page948" title="948"></span>Journals and Electronic Documents</p>
<p class="bib" id="bib2107">Afzal, A., &#x0026; Syed, N. M. (2017). Thromboelastography and thromboelastometry in patients with sepsis&#x2014;A mini-review. <em>Journal of Anesthesia and Intensive Care Medicine</em>, <em>3</em>(1), 555&#x2013;603.</p>
<p class="bib" id="bib2108">*Ahmadi, M., Poormansouri, S., Beiranvand, S., et&#x00A0;al. (2018). Predictors and correlates of fatigue in sickle cell disease patients. <em>International Journal of Hematology-Oncology &#x0026; Stem Cell Research</em>, <em>12</em>(1), 69&#x2013;76.</p>
<p class="bib" id="bib2109">Aljarad, S., Alhamid, A., Tarabishi, A. S., et&#x00A0;al. (2018). The impact of Helicobacter pylori eradication on platelet counts of adult patients with idiopathic thrombocytopenic purpura. <em>BMC Hematology</em>, <em>18</em>(28).</p>
<p class="bib" id="bib2110">Al-Qudah, H. S. (2016). Priapism treatment and management. <em>Medscape</em>. Retrieved on 9/20/2019 at: <a href="http://www.emedicine.medscape.com/article/437237-treatment">www.emedicine.medscape.com/article/437237-treatment</a></p>
<p class="bib" id="bib2111">Anderle, A., Bancone, G., Domingo, G. J., et&#x00A0;al. (2018). Point-of-care testing for G6PD deficiency: Opportunities for screening. <em>International Journal of Neonatal Screening</em>, <em>4</em>(4), 34.</p>
<p class="bib" id="bib2112">Arepally, G. M. (2017). Heparin-induced thrombocytopenia. <em>Blood</em>, <em>129</em>(21), 2864&#x2013;2872.</p>
<p class="bib" id="bib2113">*Aslani, E., Georgios, L., &#x0026; Maria, T. (2018). The measurement of fatigue in hemoglobinopathies: A systematic review of fatigue measures. <em>International Journal of Caring Science</em>, <em>11</em>(31), 1970&#x2013;1981.</p>
<p class="bib" id="bib2114">Auerbach, M., &#x0026; Adamson, J. W. (2016). How we diagnose and treat iron deficiency anemia. <em>American Journal of Hematology</em>, <em>91</em>(1), 31&#x2013;38.</p>
<p class="bib" id="bib2115">Bacon, B. R. (2019). Clinical manifestations and diagnosis of hereditary hemochromatosis. <em>UpToDate</em>. Retrieved on 1/6/2020 at: <a href="http://www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-hereditary-hemochromatosis">www.uptodate.com/contents/clinical-manifestations-and-diagnosis-of-hereditary-hemochromatosis</a></p>
<p class="bib" id="bib2116">Bonanni, P., Grazzini, M., Niccolai, G., et&#x00A0;al. (2017). Recommended vaccinations for asplenic and hyposplenic adult patients. <em>Human Vaccines &#x0026; Immunotherapeutics</em>, <em>13</em>(2), 359&#x2013;368.</p>
<p class="bib" id="bib2117">Brien, L. (2019). Anticoagulant medications for the prevention and treatment of thromboembolism. <em>Advanced Critical Care</em>, <em>30</em>(2), 126&#x2013;137.</p>
<p class="bib" id="bib2118">*Cadet, M. J. (2018). Iron deficiency anemia, a clinical case study. <em>MEDSURG Nursing</em>, <em>27</em>(2), 108&#x2013;120.</p>
<p class="bib" id="bib2119">Camaschella, C. (2019). Iron deficiency. <em>Blood</em>, <em>133</em>(1), 30&#x2013;39.</p>
<p class="bib" id="bib2120">Coates, T. D., &#x0026; Wood, J. C. (2017). How we manage, overload in sickle cell patients. <em>British Journal of Haematology</em>, <em>177</em>(5), 703&#x2013;716.</p>
<p class="bib" id="bib2121">Coutre, S. (2018). Congenital and acquired disorders of platelet function. <em>UpToDate</em>. Retrieved on 1/1/2020 at: <a href="http://www.uptodate.com/contents/congenital-and-acquired-disorders-of-platelet-function">www.uptodate.com/contents/congenital-and-acquired-disorders-of-platelet-function</a></p>
<p class="bib" id="bib2122">Darbari, D. S., &#x0026; Brandow, A. M. (2017). Pain-measurement tools in sickle cell disease: Where are we now? <em>Hematology American Society of Hematology Education Program</em>, <em>2017</em>(1), 534&#x2013;541.</p>
<p class="bib" id="bib2123">Davis, B. A., Allard, S., Qureshi, A., et&#x00A0;al. (2017). Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects. <em>British Journal of Haematology</em>, <em>178</em>(2), 179&#x2013;191.</p>
<p class="bib" id="bib2124">DeBaun, M. R. (2018). Red cell transfusion in sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/red-blood-cell-transfusion-in-sickle-cell-disease">www.uptodate.com/contents/red-blood-cell-transfusion-in-sickle-cell-disease</a></p>
<p class="bib" id="bib2125">DeBaun, M. R., &#x0026; Vichinsky, E. P. (2019). Vaso-occlusive pain management in sickle cell disease. <em>UpToDate</em>. Retrieved on 2/12/2020 at: <a href="http://www.uptodate.com/contents/vaso-occlusive-pain-management-in-sickle-cell-disease">www.uptodate.com/contents/vaso-occlusive-pain-management-in-sickle-cell-disease</a></p>
<p class="bib" id="bib2126">Depr&#x00E9;, F., Aboud, N., Ringel, F., et&#x00A0;al. (2016). Thrombopoietin receptor agonists are often ineffective in immune thrombocytopenia and/or cause adverse reactions: Results from one hand. <em>Transfusion Medicine and Hemotherapy</em>, <em>43</em>(5), 375&#x2013;379.</p>
<p class="bib" id="bib2127">El Khatib, A. M., &#x0026; Hayek, S. N. (2016). Leg ulcers in sickle cell patients: Management challenges. <em>Chronic Wound Management and Research</em>, <em>2016</em>(3), 157&#x2013;161.</p>
<p class="bib" id="bib2128">Fibach, E., &#x0026; Rachmilewitz, E. A. (2017). Pathophysiology and treatment of patients with beta-thalassemia&#x2014;an update. <em>F1000Research</em>, <em>6</em>, 2156.</p>
<p class="bib" id="bib2129">Field, J. J. (2019). Overview of management and prognosis of sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/overview-of-the-management-and-prognosis-of-sickle-cell-disease">www.uptodate.com/contents/overview-of-the-management-and-prognosis-of-sickle-cell-disease</a></p>
<p class="bib" id="bib2130">Field, J. J., Vemulakonda, V. M., DeBaun, M. R., et&#x00A0;al. (2019). Priapism and erectile dysfunction in sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/ 2019 at: <a href="http://www.uptodate.com/contents/priapism-and-erectile-dysfunction-in-sickle-cell-disease">www.uptodate.com/contents/priapism-and-erectile-dysfunction-in-sickle-cell-disease</a></p>
<p class="bib" id="bib2131">Fishbane, S., &#x0026; Spinowitz, B. (2018). Update on anemia in ESRD and early stage CKD: Core curriculum 2018. <em>American Journal of Kidney Diseases</em>, <em>71</em>(3), 423&#x2013;435.</p>
<p class="bib" id="bib2132">Franchini, M., Marano, G., Pati, I., et al. (2019). Emicizumab for the treatment of hemophilia A: A narrative review. <em>Blood Transfusion</em>, <em>17</em>, 223&#x2013;228.</p>
<p class="bib" id="bib2133">George, A. (2019). Prevention of stroke (initial or recurrent) in sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/prevention-of-stroke-initial-or-recurrent-in-sickle-cell-disease">www.uptodate.com/contents/prevention-of-stroke-initial-or-recurrent-in-sickle-cell-disease</a></p>
<p class="bib" id="bib2134">Go, R. S., Winters, J. L., &#x0026; Kay, N. E. (2017). How I treat autoimmune hemolytic anemia. <em>Blood</em>, <em>129</em>(22), 2971&#x2013;2979.</p>
<p class="bib" id="bib2135">Harper, J. L., Besa, E. C., &#x0026; Conrad, M. E. (2019). Iron deficiency anemia. <em>Medscape</em>. Retrieved on 10/1/2019 at: <a href="http://www.emedicine.medscape.com/article/202333-overview#a5">www.emedicine.medscape.com/article/202333-overview#a5</a></p>
<p class="bib" id="bib2136">Hashemi, S. M., Mashhadi, M. A., Mohammadi, M., et&#x00A0;al. (2017). <em>International Journal of Hematology Oncology and Stem Cell Research</em>, <em>11</em>(3), 192&#x2013;198.</p>
<p class="bib" id="bib2137">Heffernan, A., Evans, C., Holmes, M., et&#x00A0;al. (2017). The regulation of dietary iron bioavailability by vitamin C: A systematic review and meta-analysis. <em>Proceedings of the Nutrition Society Meeting</em>, July 10&#x2013;12, 2017.</p>
<p class="bib" id="bib2138">Hildenbrand, A. K., Quinn, C. T., Mara, C. A., et&#x00A0;al. (2019). A preliminary investigation of the psychometric properties of PROMIS&#x00AE; scales in emerging adults with sickle cell disease. <em>Health Psychology</em>, <em>38</em>(5), 386&#x2013;390.</p>
<p class="bib" id="bib2139">Hill, Q. A., Stamps, R., Massey, E., et&#x00A0;al. (2017). The diagnosis and management of primary autoimmune haemolytic anaemia. <em>British Journal of Haematology</em>, <em>17</em>(3), 395&#x2013;411.</p>
<p class="bib" id="bib2140">Holmes-Maybank, K. T., Martin, T. D., &#x0026; Duckett, A. A. (2017). What are indications, complications of acute blood transfusions in sickle cell anemia? Key points additional reading. <em>The Hospitalist</em>. Retrieved on 2/11/2020 at: <a href="http://www.the-hospitalist.org/hospitalist/article/133618/hematology/what-are-indications-complications-acute-blood-transfusions">www.the-hospitalist.org/hospitalist/article/133618/hematology/what-are-indications-complications-acute-blood-transfusions</a></p>
<p class="bib" id="bib2141">Huang, A. W., &#x0026; Muneyyirci-Delale, O. (2017). Reproductive endocrine issues in men with sickle cell anemia. <em>Andrology</em>, <em>5</em>(4), 679&#x2013;690.</p>
<p class="bib" id="bib2142">Jain, S., Bakshi, N., &#x0026; Krishnamurti, L. (2017). Acute chest syndrome in children with sickle cell disease. <em>Pediatric Allergy, Immunology, and Pulmonology</em>, <em>30</em>(4), 191&#x2013;201.</p>
<p class="bib" id="bib2143">Kanellopoulou, T., &#x0026; Nomikou, E. (2018). Replacement therapy for coronary artery bypass surgery in patients with hemophilia A and B. <em>Journal of Cardiac Surgery</em>, <em>33</em>(2), 76&#x2013;82.</p>
<p class="bib" id="bib2144">*Kim, S., Brathwaite, R., &#x0026; Kim, O. (2017). Evidence-based practice standard care for acute pain management in adults with sickle cell disease in an urgent care center. <em>Quality Management in Healthcare</em>, <em>26</em>(2), 108&#x2013;115.</p>
<p class="bib" id="bib2145">Kling, E. S., &#x0026; Farber, H. W. (2019). Pulmonary hypertension associated with sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/pulmonary-hypertension-associated-with-sickle-cell-disease">www.uptodate.com/contents/pulmonary-hypertension-associated-with-sickle-cell-disease</a></p>
<p class="bib" id="bib2146">Koupenova, M., Kehrel, B. E., Corkerey, H. A., &#x0026; Freedman, J. E. (2016). Thrombosis and platelets: An update. <em>European Heart Journal</em>, <em>38</em>(11), 785&#x2013;791.</p>
<p class="bib" id="bib2147">Kowdley, K., Brown, K., Ahn, J., et&#x00A0;al. (2019). ACG clinical guideline: Hereditary hemochromatosis. <em>American Journal of Gastroenterology</em>, <em>114</em>(8), 1202&#x2013;1218.</p>
<p class="bib" id="bib2148">Lambert, M. P., &#x0026; Gernsheimer, T. B. (2017). Clinical update in adult immune thrombocytopenia. <em>Blood</em>, <em>129</em>(21), 2829&#x2013;2835.</p>
<p class="bib" id="bib2149">Langan, R. C., &#x0026; Goodbred, A. J. (2017). Vitamin B12 deficiency: Recognition and management. <em>American Family Physician</em>, <em>96</em>(6), 384&#x2013;389.</p>
<p class="bib" id="bib2150">Lanier, J. B., Park, J. B., &#x0026; Callahan, R. C. (2018). Anemia in older adults. <em>American Family Physician</em>, <em>98</em>(7), 437&#x2013;442.</p>
<p class="bib" id="bib2151">Leebeek, F. W., &#x0026; Eikenboom, J. C. (2016). Von Willebrand&#x2019;s disease. <em>New England Journal of Medicine</em> <em>375</em>(21), 2067&#x2013;2080.</p>
<p class="bib" id="bib2152">Leung, L. K. (2019). Approach to the adult with anemia. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/approach-to-the-adult-with-anemia">www.uptodate.com/contents/approach-to-the-adult-with-anemia</a></p>
<p class="bib" id="bib2153">Lyman, G. (2019). Febrile neutropenia an ounce of prevention or a pound of cure. <em>Journal of Oncology Practice</em>, <em>15</em>(1), 27&#x2013;29.</p>
<p class="bib" id="bib2154">Mannucci, P. M. (2018). Use of desmopressin in the treatment of hemophilia A: Towards a golden jubilee. <em>Haematologica</em>, <em>103</em>(3), 379&#x2013;381.</p>
<p class="bib" id="bib2155">Mannucci, P. M. (2019). Aging with hemophilia: The challenge of appropriate drug prescription. <em>Mediterranean Journal of Hematology and Infectious Diseases</em>, <em>11</em>(1), e2019056.</p>
<p class="bib" id="bib2156">Matte, A., Zorzi, F., &#x0026; De Franceschi, L. (2019). New therapeutic options for the treatment of sickle cell disease. <em>Mediterranean Journal of Hematology and Infectious Diseases</em>, <em>11</em>(1), e2019002.</p>
<div class="pagebreak_container"><span class="pagebreak">p. 948</span><div class="rule"></div><span id="page949" class="pagebreak" epub:type="pagebreak" title="949">p. 949</span></div>
<p class="bib" id="bib2157">Miranti, E. H., Stolzenberg-Solomon, R., Weinstein, S., et&#x00A0;al. (2017). Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper intestinal tract cancer. <em>International Journal of Cancer</em>, <em>141</em>(6), 1120&#x2013;1129.</p>
<p class="bib" id="bib2158">Murao, S., &#x0026; Yamakawa, K. (2019). A systematic summary of systematic reviews on anticoagulant therapy in sepsis. <em>Journal of Clinical Medicine</em>, <em>8</em>(11), 1869.</p>
<p class="bib" id="bib2159">Murray, C., De Gelder, T., Pringle, N., et&#x00A0;al. (2016). Management of iron overload in the Canadian hematology/oncology population: Implications for nursing practice. <em>Canadian Oncology Nursing Journal</em>, <em>26</em>(1), 19&#x2013;28.</p>
<p class="bib" id="bib2160">Nagalla, S., &#x0026; Bray, P. F. (2017). Hematology: Drug-induced platelet dysfunction. <em>Cancer Therapy Advisor</em>. Retrieved on 1/1/2020 at: <a href="http://www.cancertherapyadvisor.com/home/decision-support-in-medicine/hematology/drug-induced-platelet-dysfunction">www.cancertherapyadvisor.com/home/decision-support-in-medicine/hematology/drug-induced-platelet-dysfunction</a></p>
<p class="bib" id="bib2161">National Heart Lung and Blood Institute. (2014). Evidence based management of sickle cell disease: Expert Panel Report. U.S. Department of Health and Human Services, National Institutes of Health. Retrieved on 2/11/2020 at: <a href="http://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease">www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease</a></p>
<p class="bib" id="bib2162">National Hemophilia Foundation. (2019). Hemophilia A. Retrieved on 9/23/2019 at: <a href="http://www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorders/Hemophilia-A">www.hemophilia.org/Bleeding-Disorders/Types-of-Bleeding-Disorders/Hemophilia-A</a>.</p>
<p class="bib" id="bib2163">Neunert, C., Terrell, D. R., Arnold, D. M., et&#x00A0;al. (2019). American Society of Hematology 2019 guidelines for immune thrombocytopenia. <em>Blood Advances</em>, <em>3</em>(23), 3829&#x2013;3866.</p>
<p class="bib" id="bib2164">Nomura S. (2016). Advances in diagnosis and treatments for immune thrombocytopenia. <em>Clinical Medicine Insights. Blood Disorders</em>, <em>9</em>, 15&#x2013;22.</p>
<p class="bib" id="bib2165">Okwerekwu, I., &#x0026; Skirvin, J. A. (2018). Sickle cell disease pain management. <em>U.S. Pharmacist</em>. Retrieved on 10/2/2019 at: <a href="http://www.uspharmacist.com/article/sickle-cell-disease-pain-management">www.uspharmacist.com/article/sickle-cell-disease-pain-management</a></p>
<p class="bib" id="bib2166">Ospina-Romero, M., Cannegieter, S. C., den Heijer, M., et&#x00A0;al. (2018). Hyperhomocysteinemia and risk for first venous thrombosis: The influence of (unmeasured) confounding indicators. <em>American Journal of Epidemiology</em>, <em>18</em>(7), 1392&#x2013;1400.</p>
<p class="bib" id="bib2167">Ostrakhovich, E. A., &#x0026; Tabibzadeh, S. (2019). Homocysteine and age related disorders. <em>Ageing Research Reviews</em>, <em>49</em>, 144&#x2013;164.</p>
<p class="bib" id="bib2168">Peslak, S. A., Olson, T., &#x0026; Babushok, D. V. (2017). Diagnosis and treatment of aplastic anemia. <em>Current Treatment Options in Oncology</em>, <em>18</em>(12), 70.</p>
<p class="bib" id="bib2169">Phillips, J., &#x0026; Henderson, A. C. (2018). Hemolytic anemia: Evaluation and differential diagnosis. <em>American Family Physician</em>, <em>98</em>(6), 354&#x2013;361.</p>
<p class="bib" id="bib2170">Price, E. A. (2019). Anemia in the older adult. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/anemia-in-the-older-adult">www.uptodate.com/contents/anemia-in-the-older-adult</a>.</p>
<p class="bib" id="bib2171">Razak, N. B., Jones, G., Bhandari, M., et&#x00A0;al. (2018). Cancer-associated thrombosis: An overview of mechanisms, risk factors, and treatment. <em>Cancers</em>, <em>10</em>(10), 380.</p>
<p class="bib" id="bib2172">Reding, M. T. (2018). Management insights for optimizing outcomes in the treatment of hemophilia. <em>Journal of Managed Care Medicine</em>, <em>21</em>(4). Retrieved on 2/11/2020 at: <a href="http://www.jmcmpub.org/pdf/21-4-f8">www.jmcmpub.org/pdf/21-4-f8</a></p>
<p class="bib" id="bib2173">Rick, M. E. (2019). Clinical presentation and diagnosis of von Willebrand disease. <em>UpToDate</em>. Retrieved on 1/6/2020 at: <a href="http://www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-von-willebrand-disease">www.uptodate.com/contents/clinical-presentation-and-diagnosis-of-von-willebrand-disease</a></p>
<p class="bib" id="bib2174">Schick, P. (2019). Hemolytic anemia. <em>Medscape</em>. Retrieved on 2/11/2020 at: <a href="http://www.emedicine.medscape.com/article/201066-overview">www.emedicine.medscape.com/article/201066-overview</a></p>
<p class="bib" id="bib2175">Sharma, D., &#x0026; Brandow, A. M. (2019). Neuropathic pain in individuals with sickle cell disease. <em>Neuroscience Letters</em>. Retrieved on 10/2/2019 at: doi.org/10.1016/j.neulet.2019.134445.</p>
<p class="bib" id="bib2176">Stauder, R., Valent, P., &#x0026; Theurl, I. (2018). Anemia at older age: Etiologies, clinical implications, and management. <em>Blood</em>, <em>131</em>(5), 505&#x2013;514.</p>
<p class="bib" id="bib2177">Stouten, K., Riedl, J., Droogendijk, J., et&#x00A0;al. (2016). Prevalence of potential underlying aetiology of macrocytic anaemia in Dutch general practice. <em>BMC Family Practice</em>, <em>17</em>(1), 113.</p>
<p class="bib" id="bib2178">**Taylor, F. B., Toh, C. H., Hoots, W. K., et&#x00A0;al. (2007). Towards a definition, clinical and laboratory criteria, and a scoring system for DIC. <em>Journal of Thrombosis and Haemostasis</em>, <em>5</em>(3), 445&#x2013;659.</p>
<p class="bib" id="bib2179">Thornburg, C. D., &#x0026; Duncan, N. A. (2017). Treatment adherence in hemophilia. <em>Patient Preference and Adherence</em>, <em>2017</em>(11), 1677&#x2013;1686.</p>
<p class="bib" id="bib2180">Van Wyk, H. (2018). Iron supplementation. <em>Professional Nursing Today</em>, <em>22</em>(4), 4&#x2013;6.</p>
<p class="bib" id="bib2181">Vichinsky, E. P. (2017). Overview of clinical manifestations of sickle cell disease. <em>UpToDate</em>. Retrieved on 10/1/2019 at: <a href="http://www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-sickle-cell-disease">www.uptodate.com/contents/overview-of-the-clinical-manifestations-of-sickle-cell-disease</a></p>
<p class="bib" id="bib2182">Vichinsky, E. P. (2018). Pregnancy in women with sickle cell disease. <em>UpToDate</em>. Retrieved on 10/2/2019 at: <a href="http://www.uptodate.com/contents/pregnancy-in-women-with-sickle-cell-disease">www.uptodate.com/contents/pregnancy-in-women-with-sickle-cell-disease</a></p>
<p class="bib" id="bib2183">Weiss, G., Ganz, T., &#x0026; Goodnough, L. T. (2019). Anemia of inflammation. <em>Blood</em>, <em>133</em>(1), 40&#x2013;50.</p>
<p class="bib" id="bib2184">Young, G., Liesner, R., Chang, T., et al. (2019). A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophila A with inhibitors. <em>Blood</em>, <em>134</em>(4), 2127&#x2013;2138.</p>
<p class="bib" id="bib2185">Young, N. S. (2018). Aplastic anemia. <em>New England Journal of Medicine</em>, <em>379</em>(17), 1643&#x2013;1656.</p>
<p class="BIBLIOGRAPHYpREFMGROUPpTITLE">Resources</p>
<p class="bib" id="bib2186">American Association of Blood Banks (AABB), <a href="http://www.aabb.org">www.aabb.org</a></p>
<p class="bib" id="bib2187">American Hemochromatosis Society, <a href="http://www.americanhs.org">www.americanhs.org</a></p>
<p class="bib" id="bib2188">American Red Cross, <a href="http://www.redcross.org">www.redcross.org</a></p>
<p class="bib" id="bib2189">American Society for Transplantation and Cellular Therapy, <a href="http://www.asbmt.org/home">www.asbmt.org/home</a></p>
<p class="bib" id="bib2190">Aplastic Anemia and MDS International Foundation, <a href="http://www.aamds.org">www.aamds.org</a></p>
<p class="bib" id="bib2191">APS Foundation of America (antiphospholipid syndrome), <a href="http://www.apsfa.org">www.apsfa.org</a></p>
<p class="bib" id="bib2192">G6PD Deficiency, <a href="http://www.g6pd.org">www.g6pd.org</a></p>
<p class="bib" id="bib2193">National Heart, Lung, and Blood Institute, <a href="http://www.nhlbi.nih.gov">www.nhlbi.nih.gov</a></p>
<p class="bib" id="bib2194">National Marrow Donor Program, <a href="http://www.bethematch.org">www.bethematch.org</a></p>
<p class="bib" id="bib2195">Platelet Disorder Support Association (PDSA), <a href="http://www.pdsa.org">www.pdsa.org</a></p>
<p class="bib" id="bib2196">Sickle Cell Disease Association of America (SCDAA), <a href="http://www.sicklecelldisease.org">www.sicklecelldisease.org</a></p>
</section>
</div>
</body>
</html>